Fidelis Capital Partners, LLC Edwards Lifesciences Corp Transaction History
Fidelis Capital Partners, LLC
- $840 Billion
- Q3 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 4,543 shares of EW stock, worth $323,779. This represents 0.04% of its overall portfolio holdings.
Number of Shares
4,543
Previous 5,571
18.45%
Holding current value
$323,779
Previous $340 Million
5.71%
% of portfolio
0.04%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding EW
# of Institutions
1,349Shares Held
456MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.46 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.63 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.25 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.87 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$964 Million0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $44.1B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...